Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

Glaucoma

Subtypes of Glaucoma

Open-angle glaucoma 7 Normal-tension glaucoma 2 Primary Angle Closure Glaucoma 2 Neovascular glaucoma 1 Primary congenital glaucoma 1

26 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Glaucoma

157 trials tracked for Glaucoma: 68 in phase 3 or 4 and 7 with published results. The most-cited published study has 319 citations.

157Trials tracked

68Phase 3 & 4

0Recruiting

7With published results

Phase distribution

Phase 4 45 Phase 3 23 Phase 2 13 Phase 1 5 Other / NA 71

Phase 4 Primary Tube Versus Trabeculectomy Study Completed · 319 cited
Phase 3 Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT Completed · 79 cited
Phase 4 XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) Completed · 45 cited
Phase 3 A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension Completed · 24 cited
Phase 4 Glaucoma Biomarkers Completed · 17 cited
Phase 3 Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery? Completed · 10 cited

Show 44 more trials

Phase 4 How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used? Completed · 9 cited
Phase 4 Steroids After Laser Trabeculoplasty for Glaucoma Completed
Phase 4 COSOPT-S® Treatment Versus Acetazolamide Before Trabeculectomy Completed
Phase 4 Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions Completed
Phase 4 24-hr Intraocular Pressure Control With SIMBRINZA ® Completed
Phase 4 Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Completed
Phase 4 Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID) Completed
Phase 4 Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Completed
Phase 4 Use of Bevacizumab in Trabeculectomy Surgery Completed
Phase 4 Rocklatan® Evaluation Completed
Phase 4 Comparison of Visual Field Assessments Between Three Perimeters Completed
Phase 4 Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension Completed
Phase 4 Effects of Travatan Z and Xalatan on Ocular Surface Health Completed
Phase 4 Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America Completed
Phase 4 24-hour IOP-lowering Effect of 0.01% Bimatoprost Completed
Phase 4 Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients. Completed
Phase 4 12-Month Stability of Diurnal IOP Control on Cosopt Completed
Phase 4 The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye Completed
Phase 4 An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension Completed
Phase 4 Effect of Age on Latanoprost 0.005% in Patients With Glaucoma Completed
Phase 4 Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada Completed
Phase 4 Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension Completed
Phase 4 An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects Completed
Phase 4 An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® Completed
Phase 4 Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow Completed
Phase 4 Circadian Ocular Perfusion Pressure and Ocular Blood Flow Completed
Phase 4 Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers Completed
Phase 4 Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy Completed
Phase 4 Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol Completed
Phase 4 Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension Completed
Phase 4 A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin Completed
Phase 4 A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension Completed
Phase 4 Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients Completed
Phase 4 Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma Completed
Phase 4 AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure Completed
Phase 4 A Comparison of Three Different Formulations of Prednisolone Acetate 1% Completed
Phase 4 Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) Completed
Phase 4 A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension Completed
Phase 4 Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension Completed
Phase 4 Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% Completed
Phase 4 Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan® Completed
Phase 4 Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects Completed
Phase 3 Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Completed
Phase 3 Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes Completed

Showing the 50 most-cited and recently-updated of 157 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

‹ Prev 1 2 3